Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Models of Health Promotion and Illness Prevention I01:25

Models of Health Promotion and Illness Prevention I

A model is a theoretical way to understand a concept or an idea. Models can overcome barriers to health regardless of diverse economic and cultural backgrounds. In addition, models make the task easier by providing different ways to approach complex issues. There are two major health promotion models: the health belief model and the health promotion model.
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
Models of Health Promotion and Illness Prevention II01:18

Models of Health Promotion and Illness Prevention II

The person's health status fluctuates continually, varying from being in good health to becoming ill and returning to being healthy. To understand the concept of illness prevention, there are two models. First, the health-illness continuum model is a graphic representation of an individual's wellness. It states that a person is considered healthy in the absence of physical disease and the presence of good emotional health.
The agent-host-environment model states that disease results from...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Modeling in Therapy01:26

Modeling in Therapy

Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An economic analysis of management strategies for closed and open grade I tibial shaft fractures.

Acta orthopaedica·2005
Same author

Cost-effectiveness of a community-level HIV risk reduction intervention for women living in low-income housing developments.

The journal of primary prevention·2005
Same author

A Bayesian approach to net health benefits: an illustration and application to modeling HIV prevention.

Medical decision making : an international journal of the Society for Medical Decision Making·2004
Same author

Efficacy and cost-effectiveness of the first generation of HIV prevention interventions for people with severe and persistent mental illness.

The journal of mental health policy and economics·2003
Same author

Healthy Growth: project description and baseline findings.

Ethnicity & disease·2002

Related Experiment Video

Updated: Jun 19, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

Modeling cost-effectiveness of HIV prevention programs.

Ana P Johnson-Masotti1

  • 1McMaster University, 105 Main Street East, P1 Hamilton, ON, L8N 1G6, Canada. johnmas@mcmaster.ca

Expert Review of Pharmacoeconomics & Outcomes Research
|October 8, 2009
PubMed
Summary
This summary is machine-generated.

Modeling cost-effectiveness for HIV prevention programs is crucial. Mathematical models estimate infections averted by assessing behavior change, considering community risk and intervention effectiveness.

More Related Videos

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

Related Experiment Videos

Last Updated: Jun 19, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

Area of Science:

  • Public Health
  • Health Economics
  • Epidemiology

Background:

  • Direct measurement of HIV prevention program effectiveness is challenging due to difficulties in tracking HIV incidence.
  • Effectiveness is typically inferred using mathematical models that link behavioral changes to estimated HIV infections averted.
  • Cost data are often not collected concurrently with HIV prevention interventions, complicating economic evaluations.

Purpose of the Study:

  • To review published research on modeling the cost-effectiveness of HIV prevention programs.
  • To identify key outcomes used in cost-effectiveness analyses of these interventions.
  • To discuss methodological challenges in modeling HIV prevention program cost-effectiveness.

Main Methods:

  • Review of existing literature on cost-effectiveness modeling for HIV prevention.
  • Analysis of how behavioral changes are translated into averted HIV infections using mathematical models.
  • Examination of probabilistic models of HIV transmission to estimate averted cases.

Main Results:

  • Cost-effectiveness of HIV prevention programs is frequently modeled using indirect parameters.
  • HIV prevention effectiveness estimates depend on community risk factors and intervention-induced behavioral changes.
  • Probabilistic models are utilized to compare pre- and post-intervention risk behaviors and calculate averted HIV cases.

Conclusions:

  • Mathematical modeling is essential for assessing the cost-effectiveness of HIV prevention strategies.
  • Accurate modeling requires consideration of behavioral effectiveness and community-level risk factors.
  • Addressing methodological issues in data collection and modeling is vital for robust economic evaluations of HIV prevention.